DrugCite
Search

GENINAX

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Geninax Adverse Events Reported to the FDA Over Time

How are Geninax adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Geninax, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Geninax is flagged as the suspect drug causing the adverse event.

Most Common Geninax Adverse Events Reported to the FDA

What are the most common Geninax adverse events reported to the FDA?

Hepatic Function Abnormal
7 (5.6%)
Interstitial Lung Disease
7 (5.6%)
Stevens-johnson Syndrome
5 (4%)
Hyperkalaemia
4 (3.2%)
Liver Disorder
4 (3.2%)
Platelet Count Decreased
4 (3.2%)
Torsade De Pointes
4 (3.2%)
Upper Respiratory Tract Inflammatio...
4 (3.2%)
Blood Creatine Phosphokinase Increa...
3 (2.4%)
Electrocardiogram Qt Prolonged
3 (2.4%)
Loss Of Consciousness
3 (2.4%)
Show More Show More
Pharyngitis
3 (2.4%)
Pleural Effusion
3 (2.4%)
Restlessness
3 (2.4%)
Sick Sinus Syndrome
3 (2.4%)
Uveitis
3 (2.4%)
Volvulus
3 (2.4%)
Atrioventricular Block Complete
2 (1.6%)
Endocarditis
2 (1.6%)
Erythema Multiforme
2 (1.6%)
Glaucoma
2 (1.6%)
Hepatitis
2 (1.6%)
Hypoglycaemia
2 (1.6%)
Jaundice
2 (1.6%)
Lymphadenopathy
2 (1.6%)
Pyrexia
2 (1.6%)
Renal Impairment
2 (1.6%)
Aggression
1 (.8%)
Amnesia
1 (.8%)
Angle Closure Glaucoma
1 (.8%)
Arthralgia
1 (.8%)
Cardiac Failure
1 (.8%)
Condition Aggravated
1 (.8%)
Convulsion
1 (.8%)
Delirium
1 (.8%)
Delusion
1 (.8%)
Dementia
1 (.8%)
Disease Progression
1 (.8%)
Drug Eruption
1 (.8%)
Epilepsy
1 (.8%)
Eyelid Function Disorder
1 (.8%)
Eyelid Oedema
1 (.8%)
General Physical Health Deteriorati...
1 (.8%)
Haemoptysis
1 (.8%)
Hallucination
1 (.8%)
Incorrect Dose Administered
1 (.8%)
Inflammation
1 (.8%)
Influenza
1 (.8%)
Lung Infiltration
1 (.8%)
Meningitis
1 (.8%)
Nausea
1 (.8%)
Off Label Use
1 (.8%)
Pain
1 (.8%)
Pneumonia
1 (.8%)
Pneumonia Bacterial
1 (.8%)
Rash Generalised
1 (.8%)
Renal Failure Acute
1 (.8%)
Respiratory Arrest
1 (.8%)
Rhabdomyolysis
1 (.8%)
Somnolence
1 (.8%)
Speech Disorder
1 (.8%)
Thrombocytopenia
1 (.8%)
Treatment Noncompliance
1 (.8%)
Urinary Retention
1 (.8%)
Ventricular Fibrillation
1 (.8%)
White Blood Cell Count Decreased
1 (.8%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Geninax, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Geninax is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Geninax

What are the most common Geninax adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Geninax, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Geninax is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Geninax According to Those Reporting Adverse Events

Why are people taking Geninax, according to those reporting adverse events to the FDA?

Pneumonia
16
Bronchitis
10
Pharyngitis
7
Nasopharyngitis
7
Upper Respiratory Tract Inflammatio...
4
Chronic Myeloid Leukaemia
3
Show More Show More
Pneumonia Aspiration
3
Pyrexia
3
Chlamydial Infection
2
Upper Respiratory Tract Infection
2
Chronic Obstructive Pulmonary Disea...
2
Sinusitis
2
Endocarditis
2
Antibiotic Therapy
2
Bronchopneumonia
1
Nasal Septum Deviation
1
Acute Sinusitis
1
Product Used For Unknown Indication
1
Drug Use For Unknown Indication
1
Infection
1
Respiratory Tract Infection
1
Productive Cough
1
Chronic Sinusitis
1
Prophylaxis
1
Bronchitis Chronic
1
Klebsiella Infection
1

Geninax Case Reports

What Geninax safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Geninax. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Geninax.